Operating Income Summary of Perrigo Company plc

Perrigo Company plc's latest annual operating income in 2023 was 151.9 Million USD , down -12.09% from previous year.
Perrigo Company plc's latest quarterly operating income in 2024 Q2 was 64.8 Million USD , up 175.74% from previous quarter.
Perrigo Company plc reported an annual operating income of 172.8 Million USD in 2022, down -69.88% from previous year.
Perrigo Company plc reported an annual operating income of 573.7 Million USD in 2021, down -38.47% from previous year.
Perrigo Company plc reported a quarterly operating income of 23.5 Million USD for 2024 Q1, up 250.64% from previous quarter.
Perrigo Company plc reported a quarterly operating income of 48.5 Million USD for 2023 Q1, up 56.45% from previous quarter.

Annual Operating Income Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Operating Income of Perrigo Company plc (2023 - 1992)

Year	Operating Income	Operating Income Growth
2023	151.9 Million USD	-12.09%
2022	172.8 Million USD	-69.88%
2021	573.7 Million USD	-38.47%
2020	932.4 Million USD	54.24%
2019	604.5 Million USD	155.6%
2018	236.5 Million USD	-60.46%
2017	598.2 Million USD	129.91%
2016	-1.99 Billion USD	-367.48%
2015	747.6 Million USD	31.85%
2014	567 Million USD	-16.51%
2013	679.1 Million USD	19.3%
2012	569.22 Million USD	16.12%
2011	490.2 Million USD	45.94%
2010	335.89 Million USD	35.82%
2009	247.3 Million USD	25.23%
2008	197.48 Million USD	100.38%
2007	98.55 Million USD	-11.48%
2006	111.33 Million USD	133.69%
2005	-330.47 Million USD	-421.17%
2004	102.89 Million USD	20.8%
2003	85.17 Million USD	-2.09%
2002	86.99 Million USD	116.9%
2001	40.11 Million USD	28.05%
2000	31.32 Million USD	74.03%
1999	18 Million USD	129.13%
1998	-61.8 Million USD	-185.71%
1997	72.1 Million USD	5.72%
1996	68.2 Million USD	-9.67%
1995	75.5 Million USD	-16.3%
1994	90.2 Million USD	22.72%
1993	73.5 Million USD	36.36%
1992	53.9 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	64.8 Million USD	175.74%
2024 Q1	23.5 Million USD	250.64%
2023 Q1	48.5 Million USD	56.45%
2023 Q4	-15.6 Million USD	-125.12%
2023 FY	151.9 Million USD	-12.09%
2023 Q3	62.1 Million USD	9.33%
2023 Q2	56.8 Million USD	17.11%
2022 Q3	56.2 Million USD	209.77%
2022 Q1	21.7 Million USD	-53.53%
2022 Q4	31 Million USD	-44.84%
2022 Q2	-51.2 Million USD	-335.94%
2022 FY	172.8 Million USD	-69.88%
2021 Q1	51.4 Million USD	198.47%
2021 Q3	438.3 Million USD	448.13%
2021 Q2	-125.9 Million USD	-344.94%
2021 Q4	46.7 Million USD	-89.35%
2021 FY	573.7 Million USD	-38.47%
2020 Q2	117.4 Million USD	-19.42%
2020 FY	932.4 Million USD	54.24%
2020 Q4	-52.2 Million USD	45.34%
2020 Q3	-95.5 Million USD	-181.35%
2020 Q1	145.7 Million USD	2211.59%
2019 Q1	102.3 Million USD	-4.84%
2019 Q4	-6.9 Million USD	-112.68%
2019 Q3	54.4 Million USD	-1.09%
2019 FY	604.5 Million USD	155.6%
2019 Q2	55 Million USD	-46.24%
2018 Q3	-122 Million USD	-228.83%
2018 Q4	107.5 Million USD	188.11%
2018 Q1	156.3 Million USD	-1.45%
2018 FY	236.5 Million USD	-60.46%
2018 Q2	94.7 Million USD	-39.41%
2017 Q2	148.8 Million USD	15.8%
2017 FY	598.2 Million USD	129.91%
2017 Q4	158.6 Million USD	-2.34%
2017 Q3	162.4 Million USD	9.14%
2017 Q1	128.5 Million USD	130.67%
2016 Q4	-419 Million USD	72.35%
2016 FY	-1.99 Billion USD	-367.48%
2016 Q2	238.3 Million USD	178.44%
2016 Q1	-303.8 Million USD	-222.85%
2016 Q3	-1.51 Billion USD	-735.84%
2015 Q3	188.6 Million USD	-16.88%
2015 Q2	226.9 Million USD	13.91%
2015 Q1	199.2 Million USD	8.03%
2015 FY	747.6 Million USD	31.85%
2015 Q4	-94.1 Million USD	-149.89%
2014 FY	567 Million USD	-16.51%
2014 Q1	103.3 Million USD	19.28%
2014 Q2	197.5 Million USD	91.19%
2014 Q3	137.2 Million USD	-30.53%
2014 Q4	184.4 Million USD	34.4%
2013 Q3	179.7 Million USD	-0.2%
2013 Q4	86.6 Million USD	-51.81%
2013 Q2	180.06 Million USD	0.82%
2013 Q1	178.6 Million USD	9.0%
2013 FY	679.1 Million USD	19.3%
2012 Q4	163.85 Million USD	4.65%
2012 Q1	146.07 Million USD	-9.09%
2012 Q2	160.93 Million USD	10.18%
2012 Q3	156.57 Million USD	-2.71%
2012 FY	569.22 Million USD	16.12%
2011 Q2	123.28 Million USD	0.3%
2011 FY	490.2 Million USD	45.94%
2011 Q4	160.66 Million USD	58.21%
2011 Q3	101.55 Million USD	-17.63%
2011 Q1	122.91 Million USD	-7.05%
2010 FY	335.89 Million USD	35.82%
2010 Q2	77.55 Million USD	-11.17%
2010 Q3	111.76 Million USD	44.12%
2010 Q1	87.3 Million USD	3.36%
2010 Q4	132.23 Million USD	18.32%
2009 Q1	71.89 Million USD	18.5%
2009 Q3	86.56 Million USD	55.91%
2009 FY	247.3 Million USD	25.23%
2009 Q2	55.52 Million USD	-22.77%
2009 Q4	84.46 Million USD	-2.43%
2008 FY	197.48 Million USD	100.38%
2008 Q4	60.67 Million USD	3.4%
2008 Q3	58.68 Million USD	40.26%
2008 Q1	95.12 Million USD	94.77%
2008 Q2	41.83 Million USD	-56.02%
2007 Q3	46.04 Million USD	100.9%
2007 FY	98.55 Million USD	-11.48%
2007 Q4	48.84 Million USD	6.06%
2007 Q1	23.53 Million USD	-10.82%
2007 Q2	22.92 Million USD	-2.59%
2006 Q4	26.38 Million USD	2.63%
2006 Q3	25.71 Million USD	22.79%
2006 Q2	20.93 Million USD	-31.02%
2006 FY	111.33 Million USD	133.69%
2006 Q1	30.35 Million USD	-22.78%
2005 Q2	-5.41 Million USD	98.56%
2005 Q4	39.3 Million USD	89.63%
2005 Q3	20.72 Million USD	482.52%
2005 Q1	-375.82 Million USD	-1656.29%
2005 FY	-330.47 Million USD	-421.17%
2004 Q3	26.62 Million USD	117.02%
2004 Q1	26.51 Million USD	-31.62%
2004 Q2	12.26 Million USD	-53.72%
2004 Q4	24.14 Million USD	-9.3%
2004 FY	102.89 Million USD	20.8%
2003 Q1	22.52 Million USD	-14.5%
2003 FY	85.17 Million USD	-2.09%
2003 Q4	38.77 Million USD	52.97%
2003 Q3	25.34 Million USD	285.24%
2003 Q2	6.57 Million USD	-70.79%
2002 Q1	29.86 Million USD	15.88%
2002 Q2	10.91 Million USD	-63.45%
2002 Q3	31.06 Million USD	184.55%
2002 Q4	26.34 Million USD	-15.19%
2002 FY	86.99 Million USD	116.9%
2001 Q1	14.33 Million USD	-30.05%
2001 Q3	20.45 Million USD	137.65%
2001 Q4	25.77 Million USD	26.01%
2001 FY	40.11 Million USD	28.05%
2001 Q2	8.6 Million USD	-39.95%
2000 Q2	-15.5 Million USD	-255.23%
2000 Q4	20.48 Million USD	24.66%
2000 FY	31.32 Million USD	74.03%
2000 Q1	9.98 Million USD	-47.16%
2000 Q3	16.43 Million USD	206.0%
1999 Q3	17.8 Million USD	1212.5%
1999 FY	18 Million USD	129.13%
1999 Q1	19.3 Million USD	42.96%
1999 Q2	-1.6 Million USD	-108.29%
1999 Q4	18.9 Million USD	6.18%
1998 FY	-61.8 Million USD	-185.71%
1998 Q4	13.5 Million USD	203.05%
1998 Q1	17.7 Million USD	-30.86%
1998 Q3	-13.1 Million USD	89.81%
1998 Q2	-128.5 Million USD	-825.99%
1997 Q2	14 Million USD	-24.73%
1997 Q1	18.6 Million USD	-15.84%
1997 FY	72.1 Million USD	5.72%
1997 Q4	25.6 Million USD	12.28%
1997 Q3	22.8 Million USD	62.86%
1996 Q4	22.1 Million USD	13.33%
1996 Q3	19.5 Million USD	926.32%
1996 Q2	1.9 Million USD	-90.4%
1996 Q1	19.8 Million USD	-13.54%
1996 FY	68.2 Million USD	-9.67%
1995 Q3	23.6 Million USD	129.13%
1995 FY	75.5 Million USD	-16.3%
1995 Q2	10.3 Million USD	-47.45%
1995 Q4	22.9 Million USD	-2.97%
1995 Q1	19.6 Million USD	-7.55%
1994 Q2	18.9 Million USD	-13.7%
1994 Q4	21.2 Million USD	-13.11%
1994 FY	90.2 Million USD	22.72%
1994 Q1	21.9 Million USD	-12.75%
1994 Q3	24.4 Million USD	29.1%
1993 Q2	18.4 Million USD	-0.54%
1993 Q3	24.3 Million USD	32.07%
1993 Q4	25.1 Million USD	3.29%
1993 FY	73.5 Million USD	36.36%
1993 Q1	18.5 Million USD	-4.15%
1992 Q2	13.4 Million USD	-6.94%
1992 Q4	19.3 Million USD	12.21%
1992 FY	53.9 Million USD	0.0%
1992 Q1	14.4 Million USD	5.11%
1992 Q3	17.2 Million USD	28.36%
1991 Q4	13.7 Million USD	-84.27%
1991 Q3	87.1 Million USD	0.0%

Peer Operating Income Comparison of Perrigo Company plc

Name	Operating Income	Operating Income Difference
Amneal Pharmaceuticals, Inc.	204.37 Million USD	25.675%
Bausch Health Companies Inc.	963 Million USD	84.226%
Catalent, Inc.	-749 Million USD	120.28%
Emergent BioSolutions Inc.	-726.4 Million USD	120.911%
Elanco Animal Health Incorporated	326 Million USD	53.405%
Teva Pharmaceutical Industries Limited	433 Million USD	64.919%
Zoetis Inc.	3.06 Billion USD	95.051%

Global Stocks Search

Perrigo Company plc (PRGO)

Operating Income Summary of Perrigo Company plc

Annual Operating Income Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Operating Income of Perrigo Company plc (2023 - 1992)

Peer Operating Income Comparison of Perrigo Company plc